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Abstract 
Objectives: To assess the incidence, and factors affecting conversion from robot-assisted partial 
nephrectomy (RAPN) to radical nephrectomy. 
Methods: Between November 2014 and February 2017, 501 patients underwent attempted RAPN 
by 22 surgeons at 14 centers in nine countries within the Vattikuti Collaborative Quality 
Initiative database. Patients were permanently logged for RAPN prior to surgery and were 
analysed on an intention-to-treat basis. Multivariable logistic regression with backward stepwise 
selection of variables was done to assess the factors associated with conversion to radical 
nephrectomy.  
Results: Overall conversion rate was 25/501 (4.99%). Patients converted to radical nephrectomy 
were older (median age [interquartile range] 66.0 [61.0-74.0] vs 59.0 [50.0-68.0], P=0.012), had 
higher body mass index (median 32.8 [24.9-40.9] vs. 27.8 [24.6-31.5] Kg/m
2
, P = 0.031), higher 
age-adjusted Charlson comorbidity score (median 6.0 [4.0-7.0] vs. 4.0 [3.0-5.0], P < 0.001), 
higher American Society of Anesthesiologists score (Score ≥3; 13/25 (52.0%) vs 130/476 
(27.3%), P = 0.021), Preoperative estimated glomerular filtration rate (P=0.141), clinical tumor 
stage (P=0.145), tumor location (P=0.140), multifocality (P=0.483) and RENAL nephrometry 
score (P=0.125) were not significantly different between the groups. On multivariable analysis, 
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independent predictors for conversion were BMI (odds ratio [95% CI]; 1.070 [1.018-1.124]; P = 
0.007), and Charlson score (odds ratio [95% CI]; 1.459 [1.179-1.806]; P = 0.001). 
Conclusions: RAPN was associated with a low rate of conversion. Independent predictors of 
conversion were body mass index and Charlson score. Tumor factors such as clinical stage, 
location, multifocality, or RENAL score were not associated with increased risk of conversion. 
 
Introduction 
The gold standard treatment option for patients with a small renal mass is nephron sparing 
surgery (NSS), with robot-assisted partial nephrectomy (RAPN) increasingly being used for this 
indication. 
1
 Compared to laparoscopic partial nephrectomy, RAPN is associated with a lower 
blood loss, better estimated glomerular filtration rate (eGFR) preservation, and shorter hospital 
stay.
2–4
 The enhanced instrument articulation and three-dimensional visualization afforded by a 
robot have widened its use, especially in complex cases, larger tumors, solitary kidneys 
5
 and 
also translates into a shorter learning curve. 
6–8
 
NSS is preferred over radical nephrectomy (RN) for small renal masses whenever possible 
because of equivalent oncological outcomes with a reduced risk of postoperative chronic kidney 
disease. 
9–11
 One inherent risk of NSS is the need to convert to RN. The rate of conversion to RN 
during RAPN has been quoted variably from 0% to 5.5%, which is lower than open partial 
nephrectomy (OPN) and laparoscopic partial nephrectomy.
2,4,12
 However, these studies have 
been limited to retrospective analyses, single surgeon, or single institutional design, and small 
sample sizes 
13–16
. One recent study has quoted the conversion rate at 14.5%. However, this was 
based on administrative database with use of mannitol with radical nephrectomy as a surrogate 
marker for conversion
17
.  
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Identifying factors associated with conversion can potentially identify patients who are at a 
higher risk of conversion and help patient counseling and surgical planning. With this in mind, 
we evaluated the overall rate of intraoperative conversion of RAPN to RN in a large, multi-
institutional prospective database. We also aimed to identify the preoperative and intraoperative 
patient and tumor characteristics associated with conversion to RN.   
 
Material and methods 
Data source and patient cohort 
The Vattikuti Collective Quality Initiative is a collaboration of medical institutions from around 
the world collecting high quality prospective data on robotic surgery in a web-based database. 
Within this database, we prospectively identified 502 patients who underwent attempted RAPN 
by 22 surgeons from 14 centers across nine countries between November 2014 and February 
2017. One case of conversion to open partial nephrectomy (OPN) was excluded, leaving 501 
assessable patients. Ethical committee clearance for data collection was obtained at each 
participant center. 
Definition of variables 
The variables used in this study were preoperative parameters: namely, age (patient’s age in 
years on the date of surgery), gender (male/female), side of surgery (left/right/bilateral), body 
mass index (BMI; kg/m
2
), preoperative serum creatinine in mg/dL, age-adjusted Charlson 
Comorbidity Index, American Society of Anesthesiologists (ASA) score, clinical stage (defined 
according to the American Joint Committee for Cancer, 7
th
 edition)
18
, tumor location 
(upper/mid/lower pole), multifocality (defined as two or more radiologically visible tumors in 
the same kidney preoperatively), RENAL score (radius, exophytic/endophytic properties, 
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nearness of tumor to the collecting system or sinus in millimeters, and anterior/posterior location 
relative to polar lines) 
19
, and estimated glomerular filtration rate (eGFR) calculated using the 
Cockroft-Gault formula. 
20
 Operative variables used were the surgical approach used 
(retroperitoneoscopic/transperitoneal), estimated blood loss in milliliters, warm ischemia time 
(defined as time from the clamping of the main renal artery until unclamping in minutes), and total 
operative time (time from incision until the placement of the last skin suture).  
All patients were suitable candidates for RAPN for a confirmed renal mass on preoperative 
imaging using computerized tomography. Tumors were staged using computerized tomography 
images confirmed by a radiologist. RENAL nephrometry scores were calculated using 
measurements from computerized tomography imaging. 
19
 The planned procedure was 
permanently logged as RAPN prior to the date of surgery regardless of whether intraoperative 
conversion to RN was performed. The conversion to RN was logged prospectively.  
Statistical analysis 
Frequencies and proportions were reported for categorical variables. Medians and interquartile 
ranges were reported for continuously coded variables. Chi-squared and Wilcoxon sign rank test 
were used to compare the statistical significance of differences in categorical and continuous 
variables, respectively. The analysis proceeded in two steps. First, the baseline and operative 
characteristics were compared between the non-converted (group 1) and converted (group 2) 
cohorts. Subsequently, a multivariable logistic regression with backward stepwise selection of 
variables was done to assess the factors associated with conversion to RN.  
In backward elimination, Wald test for individual variables is done. Variable with the least 
significant effect not meeting the level for staying in the model is removed. The process is 
repeated until no other effect in the model meets the specified level for removal. 
21
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All statistical tests were assessed with a significance level of P ≤ 0.05 or CI not including zero 
using SPSS version 21 (IBM Corp, Armonk, NY).  
 
Results 
The rate of conversion from intended RAPN to RN was 4.99% (25 of 501 patients). Twenty four 
were performed robotically and one using open technique. In addition to these 25 conversions to 
RN, one case was converted to OPN due to a difficult tumor dissection and the presence of four 
renal arteries. This case was excluded from analysis, as noted above. 
Table 1 describes patient and tumor characteristics of groups 1 and 2. Group 2 had a higher mean 
age at surgery (median [interquartile range]; 66.0 [61.0-74.0] vs 59.0 [50.0-68.0], P = 0.012), 
higher BMI (median 32.8 [24.9-40.9] vs. 27.8 [24.6-31.5] Kg/m
2
, P = 0.031), higher Charlson 
age-adjusted comorbidity score (median 6.0 [4.0-7.0] vs. 4.0 [3.0-5.0], P < 0.001), and was more 
likely to have an ASA score of three or greater (13/25 (52.0%) vs 130/476 (27.3%), P = 0.021). 
Sex (P = 0.192), and preoperative eGFR (P = 0.141) were not found to be statistically different 
between both groups. Tumor characteristics, which included clinical tumor stage (P = 0.145), 
tumor side (P = 0.659), tumor pole location (P = 0.140), multifocality (P = 0.483), and RENAL 
score (P = 0.125) were not statistically different between the groups. 
Table 2 compares intraoperative characteristics between the 2 groups. Estimated blood loss was 
comparable in both groups (median 100 [50-200] vs. 100 [80-200] ml, P = 0.964). There was no 
association between conversion and choice of access (P = 0.534). Out of the 25 converted cases, 
only four were converted after the application of clamp. The warm ischemia times in these 
patients were 15, 20, 20, and 30 minutes. The operative time was significantly higher in the 
converted group (p=0.011). 
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On multivariable analysis with backward stepwise selection of variables, independent predictors 
for conversion were BMI (odds ratio [95% CI]; 1.070 [1.018-1.124]; P = 0.007), and Charlson 
score (odds ratio [95% CI]; 1.459 [1.179-1.806]; P = 0.001). Age, and ASA score were not 
significant independent predictors of conversion (Table 3).  
Comment 
The conversion rate of RAPN has been reported variably in various retrospective studies. 
2,4,12
 
However, studying RAPN conversion in a retrospective setting is subject to reporting bias, as 
some procedures may be logged as the final procedure performed rather than the intended 
procedure with conversion, effectively decreasing the reported conversion rate. On the other 
hand, in administrative databases, this rate might be artificially increased due to upcoding or 
surrogate definitions for conversion.
17
 Our study is unique in that it is based on a database where 
the intended procedure is permanently logged into a web-based system prior to surgery. To our 
knowledge, this is the first prospective, multi-institutional study evaluating the conversion of 
RAPN to RN.  
Our study had several interesting findings. First, the rate of conversion of RAPN to RN was 
25/501 (4.99%). This rate is higher than 1.5% reported in a systematic review and meta-analysis 
by Choi et al., and consistent with other studies where reported rates ranged from 0% to 5.5%. 
2,4,12–16
 The higher conversion rate can be explained by our methodology where patients were 
permanently logged for RAPN prior to surgery and analysed on an ‘intention-to-treat’ basis. 
Changes in surgical planning to RN either by surgeon discretion or patient request between 
initial consult and surgery would be represented in our conversion rate. Thus, our rate is a robust 
representation of conversion based on the urologist’s initial plan for RAPN. Additionally, cases 
with a higher suspicion for requiring RN may still be boarded as a RAPN on the basis of offering 
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the possibility of NSS if the tumor is found to be amenable to resection, with a low threshold for 
conversion. Given the ~5% chance of conversion in our study, possibility of conversion may be 
included in the consent for all patients. Since these cases were documented as RAPNs converted 
to RN, this potentially includes some cases which would have otherwise been labeled RN, 
potentially inflating our rate. We believe this NSS-first approach to be common practice as there 
is no obvious disadvantage to treating cases as such prior to tumor visualization. In fact, Kara et 
al. observed that 71.9% of conversions were anticipated preoperatively, which indicates that 
many reported conversions may be a consequence of the expanding indications of NSS.
12
  
Moreover, since the standardization of NSS in renal masses < 4 cm in 2009 and its increasing 
emphasis under the 2017 American Urological Association guidelines, patients who could have 
undergone RN are now afforded RAPN even for complex tumors.
1,22
 Indeed, favorable outcomes 
have been reported in large > 4 cm, hilar, multifocal, and completely endophytic tumors, which 
has significantly broadened the feasibility of RAPN. 
23–25
  Our study encompasses a sizeable 
portion of such difficult cases; 27.3% of the total caseload (137 cases) involved clinical tumor 
stage T1b or greater, 63.7% (319 cases) had at least a medium RENAL score, and 38 cases were 
multifocal. Growing surgeon comfort with carrying out a more difficult RAPN rather than 
defaulting to RN would contribute to a higher conversion rate, although the benefit of this 
approach in terms of overall survival is not clear. 
26,27
 If it appears that the RAPN will be 
challenging, surgeons should consider the approach they feel the most comfortable to accomplish 
the goals for their patient (open/robotic or referral to experienced center) in either approach. 
Taken together, our findings suggest that conversion remains low, even for challenging tumors 
and these rates are comparable to existing literature.
2,4,12–16
 The conversion rate is significantly 
lower than Khandwala, et al, who used the definition of conversion as an event in which patients 
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were administered mannitol but received radical nephrectomy. 
17
 This definition is prone to 
upcoding, as well as downcoding potentially altering “conversion” rate. 
Another interesting finding in the present study was that estimated blood loss was not 
significantly different between the converted and non-converted patients. This might be due to 
the fact that the decision to convert is mostly taken after visualization of tumor, after which the 
hilum is controlled, directly proceeding to RN. Although the database is limited in descriptive 
details of complications, bleeding was listed as a reason for conversion in only two cases, and 
out of 25 converted cases, only 4 had clamp application before conversion, which supports that 
most conversions were not due to bleeding, and the decision to convert was likely made at an 
earlier stage prior to clamping. In addition, our results indicate that the operative time was higher 
in the converted group compared to the non-converted group. Considering the fact that in 
general, the time taken to do a radical nephrectomy is shorter than partial nephrectomy due to 
lesser steps of surgery, the finding that operative time in converted cases was, in fact, higher, 
reflects the possible failure to progress in these cases.  
Patient age, BMI, Charlson score, and ASA score were significantly different between the 
groups. It is worth noting that median preoperative eGFR in the two groups was not significantly 
different, indicating that preoperative renal function does not associate with risk of conversion. 
This finding suggests that all eligible patients were afforded NSS and eliminates a possible 
selection bias noted by Galvin et al., whereby patients with poor renal function were more likely 
to have NSS, and thus a higher risk for conversion, while those with good function were more 
likely to receive RN outright. 
14
  
Interestingly, our analysis failed to identify an association between conversion and tumor 
characteristics, such as preoperative RENAL scoring, tumor location, tumor side, and 
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multifocality. Similar findings have been observed by Png et al., who reported no association 
between RENAL score and RAPN complication rates, blood loss, conversion rate, and 
postoperative decrease in eGFR. 
28
 In addition, Komninos et al. reported no association between 
RENAL score and prediction of major complications for complex, completely endophytic 
tumors. 
24
 Notably, of the 38 multifocal RAPNs in our study, only one (4.0%) resulted in 
conversion. Thus, a complex tumor does not necessarily indicate a higher risk of conversion and 
clinicians should continue to prioritize NSS approaches whenever possible. Current literature on 
the relationship between RENAL score and operative complications including conversion are 
equivocal. Our conclusions regarding tumor complexity and conversion differ from a similar 
retrospective, single-institution study of 1023 RAPNs from 2010 to 2015 conducted by Kara et 
al. that reported a conversion rate of 3.1% with an association with RENAL score.
12
 One 
conversion was performed open due to intraoperative findings of a renal vein thrombus. Their 
finding is not surprising as complex tumors present a technical challenge to the surgeon and 
other studies have reported a similar association. 
7,14
 By comparison, our study encompasses a 
more recent pool of RAPNs from 2014 to 2017. It is possible that recent refinements in surgical 
technique and greater experience in negotiating complex tumors has led to a relative equalization 
in conversion risks.  
On the multivariable analysis, only BMI and Charlson score were found to be independently 
associated with conversion. Higher body mass index is usually associated with a larger amount 
of perinephric and hilar fat, which might possibly make delineation of the tumor more 
challenging. BMI may be a surrogate for other medical comorbidities.  If a patient has multiple 
medical comorbidities and a tumor that would require a prolonged operative time and potential 
for complications that might not be well tolerated, a surgeon might have a lower threshold to 
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convert to radical nephrectomy, particularly if the renal function was normal. Our findings differ 
from previous studies which found no association between conversion and body mass index for 
minimally invasive partial nephrectomy. 
29,30
  With a higher number of comorbidities, the 
incremental benefit of partial nephrectomy over radical nephrectomy with a normal functioning 
contralateral kidney is questionable. 
26,27
 Many of these patients have limited life expectancy, 
and thus, possibly a low threshold for RN is maintained.  
The findings of our study should be interpreted within the limitations of the observational study 
design. Our database contained incomplete information regarding the reasons for intraoperative 
conversion, details of intraoperative events leading to conversion, and whether or not the 
conversions were anticipated by the surgeon preoperatively. However, we believe that despite 
being a secondary analysis of a database which was not specifically built to answer the present 
research question, the study does add valuable insights into the true likelihood of conversion and 
potential predictive factors for conversion. Given the rarity of a conversion event, the conversion 
group was small. However, to avoid overfitting of the model, a stepwise backward elimination of 
variables was done. Despite these limitations, our study remains the only prospective, multi-
institutional series to investigate RN and open conversion as well as predictive factors. 
 
Conclusions 
To summarize, RAPN conversion to RN is rare even in challenging tumors, with a rate of 4.99% 
using a prospective, multi-institutional, intention-to-treat analysis. Conversion was associated 
with BMI and Charlson age-adjusted score. Clinical tumor stage, location, multifocality, or 
RENAL score were not associated with increased risk of conversion. 
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Table 1: Patient and tumor characteristics of converted and non-converted robot 
assisted partial nephrectomy in 501 patients operated at multiple centers in the Vattikuti 
Collective Quality Initiative database between November 2014 and February 2017.  
Analysis 
No 
Conversion 
N=476 
Conversion 
N=25 P 
Age at surgery, years, median (IQR) 
59.0 (50.0-
68.0)) 
66.0 (61.0-
74.0) 0.012 
Number of males, n (%) 327 (68.7) 14 (56.0) 0.192 
Body mass index (n=496), kg/m2, median (IQR) 
27.8 (24.6-
31.5) 
32.8 (24.9-
40.9) 0.031 
eGFR, mL/min/1.73m2, median (IQR) 
77.3 (65.8-
91.8) 
71.4 (52.6-
88.6) 0.141 
Charlson age-adjusted score (n=322), median 
(IQR) 4.0 (3.0-5.0) 6.0 (4.0-7.0) 
<0.00
1 
ASA score, n (%) 
  
0.021 
     1 104 (21.8) 2 (8.0) 
      2 241 (50.6) 10 (40.0) 
      3-4 130 (27.3) 13 (52.0) 
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Clinical tumor stage, n (%)   0.145 
     T1a 350 (73.5) 14 (56.0)  
     T1b 110 (23.1) 10 (40.0)  
     ≥T2b 16 (3.4) 1 (4.0)  
Side of tumor, n (%)   0.659 
     Left 228 (47.8) 12 (48.0)  
     Right 233 (48.9) 13 (52.0)  
     Bilateral 15 (3.2) 0 (0.0)  
Tumor location, n (%)   0.140 
     Upper pole 156 (32.8) 13 (52.0)  
     Mid pole 164 (34.5) 6 (24.0)  
     Lower pole 156 (32.8) 6 (24.0)  
Multifocality, n (%)   0.483 
     Unifocal 436 (91.6) 25 (96.0)  
     Multifocal 37 (7.8) 1 (4.0)  
RENAL nephrometry score, n (%)   0.125 
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     Low, 4-6 174 (36.5) 7 (28.0)  
     Medium, 7-9 245 (51.5) 11 (44.0)  
     High 10-12 56 (11.8) 7 (28.0)  
IQR: Interquartile range; eGFR, estimated glomerular filtration rate; ASA, American 
Society of Anesthesiologists; RENAL: radius, exophytic/endophytic properties, nearness of 
tumor to the collecting system or sinus in millimeters, and anterior/posterior location relative to 
polar lines. 
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Table 2: Intraoperative characteristics of converted and non-converted robot assisted 
partial nephrectomy in 501 patients operated at multiple centers in the Vattikuti 
Collective Quality Initiative database between November 2014 and February 2017. 
Analysis 
No Conversion 
N=476 
Conversion 
N=25 P 
Access, n (%)   0.534 
     Transperitoneal 402 (84.5) 20 (80.0)  
     Retroperitoneal 73 (15.3) 5 (20.0)  
Estimated blood loss, ml, median (IQR) 100 (80-200) 100 (50-200) 0.964 
Operative time, minutes, median (IQR) 166 (140-200) 220 (158-255) 0.011 
IQR, interquartile range 
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Table 3: Univariable and multivariable Logistic regression analysis predicting 
conversion to radical nephrectomy in 501 patients who underwent attempted robotic-
assisted radical nephrectomy at multiple centers in the Vattikuti Collective Quality 
Initiative database between November 2014 and February 2017. 
Analysis 
Univariable analysis Multivariable analysis  
OR (95% CI) P OR (95% CI) P 
Age, years 
1.046 (1.009-
1.084) 
0.013 Eliminated - 
Body mass index, kg/m2 
1.067 (1.018-
1.119) 
0.007 1.070 (1.018-1.124) 0.007 
Charlson age-adjusted score 
1.386 (1.147-
1.675) 
<0.001 1.459 (1.179-1.806) 0.001 
ASA Score ≥3 (Ref = score 
0-2)  
2.335 (1.233-
4.422) 
0.009 Eliminated - 
CI: Confidence intervals; ASA, American Society of Anesthesiologists; OR, odds ratio 
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